Bildkälla: Stockfoto

Cyxone: Follow up Comment – Negative Results in Rabeximod Covid-19 trial - Redeye

Redeye gives an additional comment on the negative top-line data from Cyxone’s Rabeximod phase II study in Moderate Covid-19 and lower our base case.

Redeye gives an additional comment on the negative top-line data from Cyxone’s Rabeximod phase II study in Moderate Covid-19 and lower our base case.
Börsvärldens nyhetsbrev
ANNONSER